Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cyclophosphamide market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cyclophosphamidemarket, defines the market attractiveness level of Cyclophosphamide market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cyclophosphamide industry, describes the types of Cyclophosphamide market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cyclophosphamide market and the development prospects and opportunities of Cyclophosphamide industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cyclophosphamide market in Chapter 13.
By Player:
Sanofi
Pfizer
Merck
Roxane
The Medicines Company
LGM Pharma
Theravance Biopharma
GLS Pharma Ltd
Baxter
Basilea Pharmaceutica
CSC PHARMACEUTICALS INTERNATIONAL
Allergan
By Type:
Cyclophosphamide Powder
Cyclophosphamide Injection
By End-User:
Cancer
Autoimmune Diseases
AL Amyloidosis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cyclophosphamide Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cyclophosphamide Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cyclophosphamide Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cyclophosphamide Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cyclophosphamide Market Analysis and Outlook to 2022
-
7.1 Global Cyclophosphamide Consumption (2017-2022)
-
7.2 United States Cyclophosphamide Consumption (2017-2022)
-
7.3 Europe Cyclophosphamide Consumption (2017-2022)
-
7.4 China Cyclophosphamide Consumption (2017-2022)
-
7.5 Japan Cyclophosphamide Consumption (2017-2022)
-
7.6 India Cyclophosphamide Consumption (2017-2022)
-
7.7 South Korea Cyclophosphamide Consumption (2017-2022)
8 Region and Country-wise Cyclophosphamide Market Analysis and Outlook to 2028
-
8.1 Global Cyclophosphamide Consumption Forecast (2022-2028)
-
8.2 United States Cyclophosphamide Consumption Forecast (2022-2028)
-
8.3 Europe Cyclophosphamide Consumption Forecast (2022-2028)
-
8.4 China Cyclophosphamide Consumption Forecast (2022-2028)
-
8.5 Japan Cyclophosphamide Consumption Forecast (2022-2028)
-
8.6 India Cyclophosphamide Consumption Forecast (2022-2028)
-
8.7 South Korea Cyclophosphamide Consumption Forecast (2022-2028)
9 Global Cyclophosphamide Market Outlook by Types and Applications to 2022
-
9.1 Global Cyclophosphamide Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cyclophosphamide Powder Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cyclophosphamide Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Cyclophosphamide Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global AL Amyloidosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Cyclophosphamide Market Outlook by Types and Applications to 2028
-
10.1 Global Cyclophosphamide Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cyclophosphamide Powder Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cyclophosphamide Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cyclophosphamide Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global AL Amyloidosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Cyclophosphamide Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cyclophosphamide Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cyclophosphamide Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cyclophosphamide Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cyclophosphamide Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Cyclophosphamide Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Cyclophosphamide Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Cyclophosphamide Product and Service
-
14.4 Roxane
-
14.4.1 Roxane Company Details
-
14.4.2 Roxane Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roxane Cyclophosphamide Product and Service
-
14.5 The Medicines Company
-
14.5.1 The Medicines Company Company Details
-
14.5.2 The Medicines Company Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 The Medicines Company Cyclophosphamide Product and Service
-
14.6 LGM Pharma
-
14.6.1 LGM Pharma Company Details
-
14.6.2 LGM Pharma Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 LGM Pharma Cyclophosphamide Product and Service
-
14.7 Theravance Biopharma
-
14.7.1 Theravance Biopharma Company Details
-
14.7.2 Theravance Biopharma Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Theravance Biopharma Cyclophosphamide Product and Service
-
14.8 GLS Pharma Ltd
-
14.8.1 GLS Pharma Ltd Company Details
-
14.8.2 GLS Pharma Ltd Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GLS Pharma Ltd Cyclophosphamide Product and Service
-
14.9 Baxter
-
14.9.1 Baxter Company Details
-
14.9.2 Baxter Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Baxter Cyclophosphamide Product and Service
-
14.10 Basilea Pharmaceutica
-
14.10.1 Basilea Pharmaceutica Company Details
-
14.10.2 Basilea Pharmaceutica Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Basilea Pharmaceutica Cyclophosphamide Product and Service
-
14.11 CSC PHARMACEUTICALS INTERNATIONAL
-
14.11.1 CSC PHARMACEUTICALS INTERNATIONAL Company Details
-
14.11.2 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Product and Service
-
14.12 Allergan
-
14.12.1 Allergan Company Details
-
14.12.2 Allergan Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Allergan Cyclophosphamide Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cyclophosphamide
-
Figure Cyclophosphamide Picture
-
Table Global Cyclophosphamide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cyclophosphamide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cyclophosphamide Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cyclophosphamide Consumption by Country (2017-2022)
-
Figure United States Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Table Europe Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Figure China Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Figure Japan Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Figure India Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cyclophosphamide Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclophosphamide Consumption Forecast by Country (2022-2028)
-
Figure United States Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cyclophosphamide Powder Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclophosphamide Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global AL Amyloidosis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclophosphamide Powder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cyclophosphamide Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AL Amyloidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cyclophosphamide Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cyclophosphamide Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cyclophosphamide Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cyclophosphamide Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cyclophosphamide Product and Service
-
Table Roxane (Foundation Year, Company Profile and etc.)
-
Table Roxane Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roxane Cyclophosphamide Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Cyclophosphamide Product and Service
-
Table LGM Pharma (Foundation Year, Company Profile and etc.)
-
Table LGM Pharma Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table LGM Pharma Cyclophosphamide Product and Service
-
Table Theravance Biopharma (Foundation Year, Company Profile and etc.)
-
Table Theravance Biopharma Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Biopharma Cyclophosphamide Product and Service
-
Table GLS Pharma Ltd (Foundation Year, Company Profile and etc.)
-
Table GLS Pharma Ltd Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table GLS Pharma Ltd Cyclophosphamide Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Cyclophosphamide Product and Service
-
Table Basilea Pharmaceutica (Foundation Year, Company Profile and etc.)
-
Table Basilea Pharmaceutica Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Basilea Pharmaceutica Cyclophosphamide Product and Service
-
Table CSC PHARMACEUTICALS INTERNATIONAL (Foundation Year, Company Profile and etc.)
-
Table CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Cyclophosphamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Cyclophosphamide Product and Service
-
